ARIAD’s petition for rehearing the Lilly NF-Kb patent lawsuit is granted by the Federal government Circuit ARIAD Pharmaceuticals, Inc. and its co-plaintiffs today announced that the U.S.S. Patent No. ARIAD is the exclusive licensee of the patents and technology. In 2006, the jury in the U.S. The jury awarded damages to the plaintiffs predicated on U.S. Sales of these two drugs through the year 2019, when the patent expires. The jury verdict was upheld in 2007 by Judge Rya W then. Zobel of the District Court who also found in favor of the plaintiffs.The rest of the cells from each participant were used for DNA extraction. DNA was extracted on the entire day the bloodstream samples were obtained, with the use of the QIAamp DNA Blood Mini Kit . Total RNA was extracted after a 24-hour incubation period, by using the RNeasy Plus Mini Kit . Information on the experimental procedures are given in the Methods section of the Supplementary Appendix. Complementary DNA Synthesis and Quantitative PCR Assay Complementary DNA was synthesized with the use of the SuperScript III First-Strand Synthesis System and oligo-dT primers .